InnoCare Pharma Ltd.SSE: 688428

The Q3 2024 Report

Nov 12, 2024 · Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 12, 2024

On 6ix: 6ix.com/news/the-q3-2024-report

The Q3 2024 Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

Announcement on Convening the Q3 2024 Performance BriefingNov 5, 2024
Announcement on Voluntary Disclosure of Phase II Clinical Trial Result of ICP-488Oct 10, 2024
Announcement on the Resignation of Non-executive Directors and Independent Non-executive Directors and the Change of Members of Special Committees of the Board of DirectorsSep 26, 2024
Announcement on Change of Sponsor Representative for Continuous SupervisionSep 21, 2024
Announcement on Listing and Circulation of Initial Public Offering of Strategic Placement Restricted SharesSep 11, 2024

Later from InnoCare Pharma

All InnoCare Pharma news releases

Follow InnoCare Pharma into a list and get an email when it puts out news.

Follow InnoCare Pharma